114 related articles for article (PubMed ID: 8700796)
1. Alopecia associated with zidovudine therapy.
Geletko SM; Segarra M; Mikolich DJ
Pharmacotherapy; 1996; 16(1):79-81. PubMed ID: 8700796
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Podzamczer D; Ferrer E; Consiglio E; Gatell JM; Perez P; Perez JL; Luna E; González A; Pedrol E; Lozano L; Ocaña I; Llibre JM; Casiró A; Aranda M; Barrufet P; Martínez-Lacasa J; Miró JM; Badía X; Casado A; Lupo S; Cahn P; Maños M; Estela J
Antivir Ther; 2002 Jun; 7(2):81-90. PubMed ID: 12212928
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine (Retrovir).
Res Initiat Treat Action; 2000 Mar; 6(1):6-7. PubMed ID: 11708188
[No Abstract] [Full Text] [Related]
5. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
6. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
[TBL] [Abstract][Full Text] [Related]
7. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
[No Abstract] [Full Text] [Related]
8. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
[TBL] [Abstract][Full Text] [Related]
9. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
10. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
11. Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection.
Williams LH; Fleckman P
Br J Dermatol; 2007 Jan; 156(1):163-4. PubMed ID: 17199585
[No Abstract] [Full Text] [Related]
12. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
[TBL] [Abstract][Full Text] [Related]
13. Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.
van Rossum AM; Geelen SP; Hartwig NG; Wolfs TF; Weemaes CM; Scherpbier HJ; van Lochem EG; Hop WC; Schutten M; Osterhaus AD; Burger DM; de Groot R
Clin Infect Dis; 2002 Apr; 34(7):1008-16. PubMed ID: 11880968
[TBL] [Abstract][Full Text] [Related]
14. Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy.
Rosenfeldt FL; Mijch A; McCrystal G; Sweeney C; Pepe S; Nicholls M; Dennett X
Int J STD AIDS; 2005 Dec; 16(12):827-9. PubMed ID: 16336769
[TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
Nerad JL; Kessler HA
Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
Moolasart P; Likanonsakul S
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
[TBL] [Abstract][Full Text] [Related]
17. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
[No Abstract] [Full Text] [Related]
18. Zidovudine.
Nurs Times; 2005 Nov 29-Dec 5; 101(48):33. PubMed ID: 16350517
[No Abstract] [Full Text] [Related]
19. Antiretroviral drug treatment for HIV/AIDS.
Goldschmidt RH; Moy A
Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838
[TBL] [Abstract][Full Text] [Related]
20. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.
Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z
Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
